Landscapes / Companies
iCell Gene Therapeutics not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
3
in active trials · 7 in all
Trials
6 active
12 since 2021
Drugs3
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 2 | 7 Apr 2028Phase 1/2 trial completes | |||
| Next date | 7 Apr 2028 · Phase 1/2 trial completes | ||||
| Also tested for | Systemic Lupus Erythematosus (SLE), Lupus Nephritis (LN) and 2 more | ||||
| Open drug page | |||||
— |
Phase 1 | 4 Jul 2028Phase 1 trial completes | |||
| Next date | 4 Jul 2028 · Phase 1 trial completes | ||||
| Also tested for | Acute Myeloid Leukemia (AML) | ||||
| Open drug page | |||||
— |
Phase 1 | — | |||
| Also tested for | Multiple Myeloma in Relapse, Refractory Multiple Myeloma and 2 more | ||||
| Open drug page | |||||
About
- No active trial
- anti-CD33 CAR T cells, anti-CD5 CAR T cells, CD4 CAR T cells, CD7 CAR T cells
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021